Eligibility for Entry into First Line Metastatic Trials in Patients with Disease Recurrence within 12 Months of Adjuvant Chemotherapy for Early Stage Breast Cancer. Issue 6 (June 2015) - Bhattacharya, I.S.; Hussain, T.; Kadam, M.; Sutherland, S.; Ho, A.; Bernhardt, V.; Ah-See, M.L.; Shah, N.; Ostler, P.; Miles, D.; Makris, A.